Where Research Is Heading / What to Watch For Larger RCTs in non-diabetic or prediabetic populations specifically targeting cognitive decline or dementia as endpoints
Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China
Generic biosimilar insulin glargine products have also begun to enter the market, potentially reducing costs for patients who need this medication class
Microorganisms 9 , 2376 (2021)
The Trump administrations recent announcement on most-favored-nation pricing, which would dramatically reduce prices Americans pay for obesity management medications, such as WeGovy and Ozempic is a promising sign that the obesity epidemic is being taken seriously at the federal level, but theres still plenty of work to do at home
The moment a drug comes off the shortage list, the temporary permission to compound copies expires